Company Number: 14785243

Analysis Date: 2025-07-20 12:49 UTC

1. Credit Opinion: DECLINE. Edge Diagnostics Ltd is a very recently incorporated entity (April 2023) with less than one full year of financial history. Its latest accounts to April 2024 show net current liabilities and negative net assets (£-381), indicating a weak balance sheet and insufficient working capital to cover short-term obligations. There is no evidence of operating profit or retained earnings, and the company has no employees besides directors. The small cash balance (£13,675) is marginal relative to current liabilities (£55,675), suggesting potential liquidity constraints. Given these factors and lack of trading track record, the risk of default is high. Without additional financial support or guarantees, credit facilities would be unattractive.

2. Financial Strength: The balance sheet reveals net liabilities of £381, with current liabilities slightly exceeding current assets. The company’s share capital is nominal (£3), and accumulated losses outweigh equity. Absence of fixed assets or long-term investments further limits collateral value. The company meets the micro-entity filing criteria and is exempt from audit, which limits transparency. Negative shareholders’ funds and net current liabilities reflect fragile financial standing, typical of a start-up but a concern for credit risk.

3. Cash Flow Assessment: Cash on hand is £13,675, which covers only about 25% of current liabilities. Debtors (£41,619) largely comprise trade receivables, but collection risk exists as the company is new and has no track record. The net working capital deficit (-£381) indicates potential short-term liquidity pressure. No employees are reported, so payroll outflows are minimal, but creditor balances are relatively high compared to cash resources. Overall, liquidity appears tight with limited buffer to absorb shocks or delays in cash inflows.

4. Monitoring Points:

• Monitor subsequent trading performance and profitability once more financial data is available.
• Track cash flow trends and debtor collection efficiency.
• Watch for improvements in net current assets and equity position.
• Review director changes or additional capital injections.
• Assess any emerging credit facilities or guarantees that improve financial resilience.
• Follow updates on payment behavior and supplier relationships.